Home » Psychology news » Migraine prevention: Monoclonal antibodies could become additional therapy option

Migraine prevention: Monoclonal antibodies could become additional therapy option

May 31, 2016 by

Researchers are focused on preventing or shortening the duration of migraine attacks by looking at established drug treatment options and those that could shape future therapies.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>